Global Point-of-care Testing (POCT) for Substance Abuse Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Point-of-care Testing (POCT) for Substance Abuse market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Point-of-care Testing (POCT) for Substance Abuse market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Point-of-care Testing (POCT) for Substance Abuse market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Point-of-care Testing (POCT) for Substance Abuse market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Point-of-care Testing (POCT) for Substance Abuse market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Point-of-care Testing (POCT) for Substance Abuse market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Point-of-care Testing (POCT) for Substance Abuse
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Point-of-care Testing (POCT) for Substance Abuse market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Danaher, Abbott, Siemens and Beijing Hotgen Biotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Point-of-care Testing (POCT) for Substance Abuse market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Point-of-care Testing (POCT) for Substance Abuse product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Point-of-care Testing (POCT) for Substance Abuse, with price, sales, revenue and global market share of Point-of-care Testing (POCT) for Substance Abuse from 2018 to 2023.
Chapter 3, the Point-of-care Testing (POCT) for Substance Abuse competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Point-of-care Testing (POCT) for Substance Abuse breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Point-of-care Testing (POCT) for Substance Abuse market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Point-of-care Testing (POCT) for Substance Abuse.
Chapter 14 and 15, to describe Point-of-care Testing (POCT) for Substance Abuse sales channel, distributors, customers, research findings and conclusion.
This report is a detailed and comprehensive analysis for global Point-of-care Testing (POCT) for Substance Abuse market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Point-of-care Testing (POCT) for Substance Abuse market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Point-of-care Testing (POCT) for Substance Abuse market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Point-of-care Testing (POCT) for Substance Abuse market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Point-of-care Testing (POCT) for Substance Abuse market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Point-of-care Testing (POCT) for Substance Abuse
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Point-of-care Testing (POCT) for Substance Abuse market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Danaher, Abbott, Siemens and Beijing Hotgen Biotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Point-of-care Testing (POCT) for Substance Abuse market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Based on Colloidal Gold
- Based on Fluorescence Immunochromatography
- Hospital
- Diagnostic Center
- Road Traffic Safety
- Military
- Others
- Roche
- Danaher
- Abbott
- Siemens
- Beijing Hotgen Biotech
- Hangzhou Biotest Biotech CO.,LTD
- Assure Tech
- Orient Gene
- Thermo Fisher
- Guangzhou Wondfo Biotech Co.,Ltd.
- Hangzhou Alltest Biotech Co.,Ltd.
- Beckman Coulter
- Bio-Rad
- BioMerieux
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Point-of-care Testing (POCT) for Substance Abuse product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Point-of-care Testing (POCT) for Substance Abuse, with price, sales, revenue and global market share of Point-of-care Testing (POCT) for Substance Abuse from 2018 to 2023.
Chapter 3, the Point-of-care Testing (POCT) for Substance Abuse competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Point-of-care Testing (POCT) for Substance Abuse breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Point-of-care Testing (POCT) for Substance Abuse market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Point-of-care Testing (POCT) for Substance Abuse.
Chapter 14 and 15, to describe Point-of-care Testing (POCT) for Substance Abuse sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Point-of-care Testing (POCT) for Substance Abuse
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Based on Colloidal Gold
1.3.3 Based on Fluorescence Immunochromatography
1.4 Market Analysis by Application
1.4.1 Overview: Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Diagnostic Center
1.4.4 Road Traffic Safety
1.4.5 Military
1.4.6 Others
1.5 Global Point-of-care Testing (POCT) for Substance Abuse Market Size & Forecast
1.5.1 Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Point-of-care Testing (POCT) for Substance Abuse Sales Quantity (2018-2029)
1.5.3 Global Point-of-care Testing (POCT) for Substance Abuse Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Point-of-care Testing (POCT) for Substance Abuse Product and Services
2.1.4 Roche Point-of-care Testing (POCT) for Substance Abuse Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Roche Recent Developments/Updates
2.2 Danaher
2.2.1 Danaher Details
2.2.2 Danaher Major Business
2.2.3 Danaher Point-of-care Testing (POCT) for Substance Abuse Product and Services
2.2.4 Danaher Point-of-care Testing (POCT) for Substance Abuse Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Danaher Recent Developments/Updates
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business
2.3.3 Abbott Point-of-care Testing (POCT) for Substance Abuse Product and Services
2.3.4 Abbott Point-of-care Testing (POCT) for Substance Abuse Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Abbott Recent Developments/Updates
2.4 Siemens
2.4.1 Siemens Details
2.4.2 Siemens Major Business
2.4.3 Siemens Point-of-care Testing (POCT) for Substance Abuse Product and Services
2.4.4 Siemens Point-of-care Testing (POCT) for Substance Abuse Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Siemens Recent Developments/Updates
2.5 Beijing Hotgen Biotech
2.5.1 Beijing Hotgen Biotech Details
2.5.2 Beijing Hotgen Biotech Major Business
2.5.3 Beijing Hotgen Biotech Point-of-care Testing (POCT) for Substance Abuse Product and Services
2.5.4 Beijing Hotgen Biotech Point-of-care Testing (POCT) for Substance Abuse Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Beijing Hotgen Biotech Recent Developments/Updates
2.6 Hangzhou Biotest Biotech CO.,LTD
2.6.1 Hangzhou Biotest Biotech CO.,LTD Details
2.6.2 Hangzhou Biotest Biotech CO.,LTD Major Business
2.6.3 Hangzhou Biotest Biotech CO.,LTD Point-of-care Testing (POCT) for Substance Abuse Product and Services
2.6.4 Hangzhou Biotest Biotech CO.,LTD Point-of-care Testing (POCT) for Substance Abuse Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Hangzhou Biotest Biotech CO.,LTD Recent Developments/Updates
2.7 Assure Tech
2.7.1 Assure Tech Details
2.7.2 Assure Tech Major Business
2.7.3 Assure Tech Point-of-care Testing (POCT) for Substance Abuse Product and Services
2.7.4 Assure Tech Point-of-care Testing (POCT) for Substance Abuse Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Assure Tech Recent Developments/Updates
2.8 Orient Gene
2.8.1 Orient Gene Details
2.8.2 Orient Gene Major Business
2.8.3 Orient Gene Point-of-care Testing (POCT) for Substance Abuse Product and Services
2.8.4 Orient Gene Point-of-care Testing (POCT) for Substance Abuse Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Orient Gene Recent Developments/Updates
2.9 Thermo Fisher
2.9.1 Thermo Fisher Details
2.9.2 Thermo Fisher Major Business
2.9.3 Thermo Fisher Point-of-care Testing (POCT) for Substance Abuse Product and Services
2.9.4 Thermo Fisher Point-of-care Testing (POCT) for Substance Abuse Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Thermo Fisher Recent Developments/Updates
2.10 Guangzhou Wondfo Biotech Co.,Ltd.
2.10.1 Guangzhou Wondfo Biotech Co.,Ltd. Details
2.10.2 Guangzhou Wondfo Biotech Co.,Ltd. Major Business
2.10.3 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Product and Services
2.10.4 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments/Updates
2.11 Hangzhou Alltest Biotech Co.,Ltd.
2.11.1 Hangzhou Alltest Biotech Co.,Ltd. Details
2.11.2 Hangzhou Alltest Biotech Co.,Ltd. Major Business
2.11.3 Hangzhou Alltest Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Product and Services
2.11.4 Hangzhou Alltest Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Hangzhou Alltest Biotech Co.,Ltd. Recent Developments/Updates
2.12 Beckman Coulter
2.12.1 Beckman Coulter Details
2.12.2 Beckman Coulter Major Business
2.12.3 Beckman Coulter Point-of-care Testing (POCT) for Substance Abuse Product and Services
2.12.4 Beckman Coulter Point-of-care Testing (POCT) for Substance Abuse Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Beckman Coulter Recent Developments/Updates
2.13 Bio-Rad
2.13.1 Bio-Rad Details
2.13.2 Bio-Rad Major Business
2.13.3 Bio-Rad Point-of-care Testing (POCT) for Substance Abuse Product and Services
2.13.4 Bio-Rad Point-of-care Testing (POCT) for Substance Abuse Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Bio-Rad Recent Developments/Updates
2.14 BioMerieux
2.14.1 BioMerieux Details
2.14.2 BioMerieux Major Business
2.14.3 BioMerieux Point-of-care Testing (POCT) for Substance Abuse Product and Services
2.14.4 BioMerieux Point-of-care Testing (POCT) for Substance Abuse Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 BioMerieux Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: POINT-OF-CARE TESTING (POCT) FOR SUBSTANCE ABUSE BY MANUFACTURER
3.1 Global Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Manufacturer (2018-2023)
3.2 Global Point-of-care Testing (POCT) for Substance Abuse Revenue by Manufacturer (2018-2023)
3.3 Global Point-of-care Testing (POCT) for Substance Abuse Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Point-of-care Testing (POCT) for Substance Abuse by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Point-of-care Testing (POCT) for Substance Abuse Manufacturer Market Share in 2022
3.4.2 Top 6 Point-of-care Testing (POCT) for Substance Abuse Manufacturer Market Share in 2022
3.5 Point-of-care Testing (POCT) for Substance Abuse Market: Overall Company Footprint Analysis
3.5.1 Point-of-care Testing (POCT) for Substance Abuse Market: Region Footprint
3.5.2 Point-of-care Testing (POCT) for Substance Abuse Market: Company Product Type Footprint
3.5.3 Point-of-care Testing (POCT) for Substance Abuse Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Point-of-care Testing (POCT) for Substance Abuse Market Size by Region
4.1.1 Global Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Region (2018-2029)
4.1.2 Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Region (2018-2029)
4.1.3 Global Point-of-care Testing (POCT) for Substance Abuse Average Price by Region (2018-2029)
4.2 North America Point-of-care Testing (POCT) for Substance Abuse Consumption Value (2018-2029)
4.3 Europe Point-of-care Testing (POCT) for Substance Abuse Consumption Value (2018-2029)
4.4 Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Consumption Value (2018-2029)
4.5 South America Point-of-care Testing (POCT) for Substance Abuse Consumption Value (2018-2029)
4.6 Middle East and Africa Point-of-care Testing (POCT) for Substance Abuse Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Type (2018-2029)
5.2 Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Type (2018-2029)
5.3 Global Point-of-care Testing (POCT) for Substance Abuse Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Application (2018-2029)
6.2 Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Application (2018-2029)
6.3 Global Point-of-care Testing (POCT) for Substance Abuse Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Type (2018-2029)
7.2 North America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Application (2018-2029)
7.3 North America Point-of-care Testing (POCT) for Substance Abuse Market Size by Country
7.3.1 North America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Country (2018-2029)
7.3.2 North America Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Type (2018-2029)
8.2 Europe Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Application (2018-2029)
8.3 Europe Point-of-care Testing (POCT) for Substance Abuse Market Size by Country
8.3.1 Europe Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Country (2018-2029)
8.3.2 Europe Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Market Size by Region
9.3.1 Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Type (2018-2029)
10.2 South America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Application (2018-2029)
10.3 South America Point-of-care Testing (POCT) for Substance Abuse Market Size by Country
10.3.1 South America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Country (2018-2029)
10.3.2 South America Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Market Size by Country
11.3.1 Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Point-of-care Testing (POCT) for Substance Abuse Market Drivers
12.2 Point-of-care Testing (POCT) for Substance Abuse Market Restraints
12.3 Point-of-care Testing (POCT) for Substance Abuse Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Point-of-care Testing (POCT) for Substance Abuse and Key Manufacturers
13.2 Manufacturing Costs Percentage of Point-of-care Testing (POCT) for Substance Abuse
13.3 Point-of-care Testing (POCT) for Substance Abuse Production Process
13.4 Point-of-care Testing (POCT) for Substance Abuse Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Point-of-care Testing (POCT) for Substance Abuse Typical Distributors
14.3 Point-of-care Testing (POCT) for Substance Abuse Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Point-of-care Testing (POCT) for Substance Abuse
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Based on Colloidal Gold
1.3.3 Based on Fluorescence Immunochromatography
1.4 Market Analysis by Application
1.4.1 Overview: Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Diagnostic Center
1.4.4 Road Traffic Safety
1.4.5 Military
1.4.6 Others
1.5 Global Point-of-care Testing (POCT) for Substance Abuse Market Size & Forecast
1.5.1 Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Point-of-care Testing (POCT) for Substance Abuse Sales Quantity (2018-2029)
1.5.3 Global Point-of-care Testing (POCT) for Substance Abuse Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Point-of-care Testing (POCT) for Substance Abuse Product and Services
2.1.4 Roche Point-of-care Testing (POCT) for Substance Abuse Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Roche Recent Developments/Updates
2.2 Danaher
2.2.1 Danaher Details
2.2.2 Danaher Major Business
2.2.3 Danaher Point-of-care Testing (POCT) for Substance Abuse Product and Services
2.2.4 Danaher Point-of-care Testing (POCT) for Substance Abuse Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Danaher Recent Developments/Updates
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business
2.3.3 Abbott Point-of-care Testing (POCT) for Substance Abuse Product and Services
2.3.4 Abbott Point-of-care Testing (POCT) for Substance Abuse Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Abbott Recent Developments/Updates
2.4 Siemens
2.4.1 Siemens Details
2.4.2 Siemens Major Business
2.4.3 Siemens Point-of-care Testing (POCT) for Substance Abuse Product and Services
2.4.4 Siemens Point-of-care Testing (POCT) for Substance Abuse Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Siemens Recent Developments/Updates
2.5 Beijing Hotgen Biotech
2.5.1 Beijing Hotgen Biotech Details
2.5.2 Beijing Hotgen Biotech Major Business
2.5.3 Beijing Hotgen Biotech Point-of-care Testing (POCT) for Substance Abuse Product and Services
2.5.4 Beijing Hotgen Biotech Point-of-care Testing (POCT) for Substance Abuse Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Beijing Hotgen Biotech Recent Developments/Updates
2.6 Hangzhou Biotest Biotech CO.,LTD
2.6.1 Hangzhou Biotest Biotech CO.,LTD Details
2.6.2 Hangzhou Biotest Biotech CO.,LTD Major Business
2.6.3 Hangzhou Biotest Biotech CO.,LTD Point-of-care Testing (POCT) for Substance Abuse Product and Services
2.6.4 Hangzhou Biotest Biotech CO.,LTD Point-of-care Testing (POCT) for Substance Abuse Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Hangzhou Biotest Biotech CO.,LTD Recent Developments/Updates
2.7 Assure Tech
2.7.1 Assure Tech Details
2.7.2 Assure Tech Major Business
2.7.3 Assure Tech Point-of-care Testing (POCT) for Substance Abuse Product and Services
2.7.4 Assure Tech Point-of-care Testing (POCT) for Substance Abuse Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Assure Tech Recent Developments/Updates
2.8 Orient Gene
2.8.1 Orient Gene Details
2.8.2 Orient Gene Major Business
2.8.3 Orient Gene Point-of-care Testing (POCT) for Substance Abuse Product and Services
2.8.4 Orient Gene Point-of-care Testing (POCT) for Substance Abuse Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Orient Gene Recent Developments/Updates
2.9 Thermo Fisher
2.9.1 Thermo Fisher Details
2.9.2 Thermo Fisher Major Business
2.9.3 Thermo Fisher Point-of-care Testing (POCT) for Substance Abuse Product and Services
2.9.4 Thermo Fisher Point-of-care Testing (POCT) for Substance Abuse Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Thermo Fisher Recent Developments/Updates
2.10 Guangzhou Wondfo Biotech Co.,Ltd.
2.10.1 Guangzhou Wondfo Biotech Co.,Ltd. Details
2.10.2 Guangzhou Wondfo Biotech Co.,Ltd. Major Business
2.10.3 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Product and Services
2.10.4 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments/Updates
2.11 Hangzhou Alltest Biotech Co.,Ltd.
2.11.1 Hangzhou Alltest Biotech Co.,Ltd. Details
2.11.2 Hangzhou Alltest Biotech Co.,Ltd. Major Business
2.11.3 Hangzhou Alltest Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Product and Services
2.11.4 Hangzhou Alltest Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Hangzhou Alltest Biotech Co.,Ltd. Recent Developments/Updates
2.12 Beckman Coulter
2.12.1 Beckman Coulter Details
2.12.2 Beckman Coulter Major Business
2.12.3 Beckman Coulter Point-of-care Testing (POCT) for Substance Abuse Product and Services
2.12.4 Beckman Coulter Point-of-care Testing (POCT) for Substance Abuse Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Beckman Coulter Recent Developments/Updates
2.13 Bio-Rad
2.13.1 Bio-Rad Details
2.13.2 Bio-Rad Major Business
2.13.3 Bio-Rad Point-of-care Testing (POCT) for Substance Abuse Product and Services
2.13.4 Bio-Rad Point-of-care Testing (POCT) for Substance Abuse Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Bio-Rad Recent Developments/Updates
2.14 BioMerieux
2.14.1 BioMerieux Details
2.14.2 BioMerieux Major Business
2.14.3 BioMerieux Point-of-care Testing (POCT) for Substance Abuse Product and Services
2.14.4 BioMerieux Point-of-care Testing (POCT) for Substance Abuse Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 BioMerieux Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: POINT-OF-CARE TESTING (POCT) FOR SUBSTANCE ABUSE BY MANUFACTURER
3.1 Global Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Manufacturer (2018-2023)
3.2 Global Point-of-care Testing (POCT) for Substance Abuse Revenue by Manufacturer (2018-2023)
3.3 Global Point-of-care Testing (POCT) for Substance Abuse Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Point-of-care Testing (POCT) for Substance Abuse by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Point-of-care Testing (POCT) for Substance Abuse Manufacturer Market Share in 2022
3.4.2 Top 6 Point-of-care Testing (POCT) for Substance Abuse Manufacturer Market Share in 2022
3.5 Point-of-care Testing (POCT) for Substance Abuse Market: Overall Company Footprint Analysis
3.5.1 Point-of-care Testing (POCT) for Substance Abuse Market: Region Footprint
3.5.2 Point-of-care Testing (POCT) for Substance Abuse Market: Company Product Type Footprint
3.5.3 Point-of-care Testing (POCT) for Substance Abuse Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Point-of-care Testing (POCT) for Substance Abuse Market Size by Region
4.1.1 Global Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Region (2018-2029)
4.1.2 Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Region (2018-2029)
4.1.3 Global Point-of-care Testing (POCT) for Substance Abuse Average Price by Region (2018-2029)
4.2 North America Point-of-care Testing (POCT) for Substance Abuse Consumption Value (2018-2029)
4.3 Europe Point-of-care Testing (POCT) for Substance Abuse Consumption Value (2018-2029)
4.4 Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Consumption Value (2018-2029)
4.5 South America Point-of-care Testing (POCT) for Substance Abuse Consumption Value (2018-2029)
4.6 Middle East and Africa Point-of-care Testing (POCT) for Substance Abuse Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Type (2018-2029)
5.2 Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Type (2018-2029)
5.3 Global Point-of-care Testing (POCT) for Substance Abuse Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Application (2018-2029)
6.2 Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Application (2018-2029)
6.3 Global Point-of-care Testing (POCT) for Substance Abuse Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Type (2018-2029)
7.2 North America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Application (2018-2029)
7.3 North America Point-of-care Testing (POCT) for Substance Abuse Market Size by Country
7.3.1 North America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Country (2018-2029)
7.3.2 North America Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Type (2018-2029)
8.2 Europe Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Application (2018-2029)
8.3 Europe Point-of-care Testing (POCT) for Substance Abuse Market Size by Country
8.3.1 Europe Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Country (2018-2029)
8.3.2 Europe Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Market Size by Region
9.3.1 Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Type (2018-2029)
10.2 South America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Application (2018-2029)
10.3 South America Point-of-care Testing (POCT) for Substance Abuse Market Size by Country
10.3.1 South America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Country (2018-2029)
10.3.2 South America Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Market Size by Country
11.3.1 Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Point-of-care Testing (POCT) for Substance Abuse Market Drivers
12.2 Point-of-care Testing (POCT) for Substance Abuse Market Restraints
12.3 Point-of-care Testing (POCT) for Substance Abuse Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Point-of-care Testing (POCT) for Substance Abuse and Key Manufacturers
13.2 Manufacturing Costs Percentage of Point-of-care Testing (POCT) for Substance Abuse
13.3 Point-of-care Testing (POCT) for Substance Abuse Production Process
13.4 Point-of-care Testing (POCT) for Substance Abuse Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Point-of-care Testing (POCT) for Substance Abuse Typical Distributors
14.3 Point-of-care Testing (POCT) for Substance Abuse Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 6. Roche Point-of-care Testing (POCT) for Substance Abuse Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Roche Recent Developments/Updates
Table 8. Danaher Basic Information, Manufacturing Base and Competitors
Table 9. Danaher Major Business
Table 10. Danaher Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 11. Danaher Point-of-care Testing (POCT) for Substance Abuse Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Danaher Recent Developments/Updates
Table 13. Abbott Basic Information, Manufacturing Base and Competitors
Table 14. Abbott Major Business
Table 15. Abbott Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 16. Abbott Point-of-care Testing (POCT) for Substance Abuse Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Abbott Recent Developments/Updates
Table 18. Siemens Basic Information, Manufacturing Base and Competitors
Table 19. Siemens Major Business
Table 20. Siemens Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 21. Siemens Point-of-care Testing (POCT) for Substance Abuse Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Siemens Recent Developments/Updates
Table 23. Beijing Hotgen Biotech Basic Information, Manufacturing Base and Competitors
Table 24. Beijing Hotgen Biotech Major Business
Table 25. Beijing Hotgen Biotech Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 26. Beijing Hotgen Biotech Point-of-care Testing (POCT) for Substance Abuse Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Beijing Hotgen Biotech Recent Developments/Updates
Table 28. Hangzhou Biotest Biotech CO.,LTD Basic Information, Manufacturing Base and Competitors
Table 29. Hangzhou Biotest Biotech CO.,LTD Major Business
Table 30. Hangzhou Biotest Biotech CO.,LTD Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 31. Hangzhou Biotest Biotech CO.,LTD Point-of-care Testing (POCT) for Substance Abuse Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Hangzhou Biotest Biotech CO.,LTD Recent Developments/Updates
Table 33. Assure Tech Basic Information, Manufacturing Base and Competitors
Table 34. Assure Tech Major Business
Table 35. Assure Tech Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 36. Assure Tech Point-of-care Testing (POCT) for Substance Abuse Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Assure Tech Recent Developments/Updates
Table 38. Orient Gene Basic Information, Manufacturing Base and Competitors
Table 39. Orient Gene Major Business
Table 40. Orient Gene Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 41. Orient Gene Point-of-care Testing (POCT) for Substance Abuse Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Orient Gene Recent Developments/Updates
Table 43. Thermo Fisher Basic Information, Manufacturing Base and Competitors
Table 44. Thermo Fisher Major Business
Table 45. Thermo Fisher Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 46. Thermo Fisher Point-of-care Testing (POCT) for Substance Abuse Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Thermo Fisher Recent Developments/Updates
Table 48. Guangzhou Wondfo Biotech Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 49. Guangzhou Wondfo Biotech Co.,Ltd. Major Business
Table 50. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 51. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments/Updates
Table 53. Hangzhou Alltest Biotech Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 54. Hangzhou Alltest Biotech Co.,Ltd. Major Business
Table 55. Hangzhou Alltest Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 56. Hangzhou Alltest Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Hangzhou Alltest Biotech Co.,Ltd. Recent Developments/Updates
Table 58. Beckman Coulter Basic Information, Manufacturing Base and Competitors
Table 59. Beckman Coulter Major Business
Table 60. Beckman Coulter Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 61. Beckman Coulter Point-of-care Testing (POCT) for Substance Abuse Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Beckman Coulter Recent Developments/Updates
Table 63. Bio-Rad Basic Information, Manufacturing Base and Competitors
Table 64. Bio-Rad Major Business
Table 65. Bio-Rad Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 66. Bio-Rad Point-of-care Testing (POCT) for Substance Abuse Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Bio-Rad Recent Developments/Updates
Table 68. BioMerieux Basic Information, Manufacturing Base and Competitors
Table 69. BioMerieux Major Business
Table 70. BioMerieux Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 71. BioMerieux Point-of-care Testing (POCT) for Substance Abuse Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. BioMerieux Recent Developments/Updates
Table 73. Global Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 74. Global Point-of-care Testing (POCT) for Substance Abuse Revenue by Manufacturer (2018-2023) & (USD Million)
Table 75. Global Point-of-care Testing (POCT) for Substance Abuse Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 76. Market Position of Manufacturers in Point-of-care Testing (POCT) for Substance Abuse, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 77. Head Office and Point-of-care Testing (POCT) for Substance Abuse Production Site of Key Manufacturer
Table 78. Point-of-care Testing (POCT) for Substance Abuse Market: Company Product Type Footprint
Table 79. Point-of-care Testing (POCT) for Substance Abuse Market: Company Product Application Footprint
Table 80. Point-of-care Testing (POCT) for Substance Abuse New Market Entrants and Barriers to Market Entry
Table 81. Point-of-care Testing (POCT) for Substance Abuse Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Region (2018-2023) & (K Units)
Table 83. Global Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Region (2024-2029) & (K Units)
Table 84. Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Region (2018-2023) & (USD Million)
Table 85. Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Region (2024-2029) & (USD Million)
Table 86. Global Point-of-care Testing (POCT) for Substance Abuse Average Price by Region (2018-2023) & (US$/Unit)
Table 87. Global Point-of-care Testing (POCT) for Substance Abuse Average Price by Region (2024-2029) & (US$/Unit)
Table 88. Global Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Global Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Global Point-of-care Testing (POCT) for Substance Abuse Average Price by Type (2018-2023) & (US$/Unit)
Table 93. Global Point-of-care Testing (POCT) for Substance Abuse Average Price by Type (2024-2029) & (US$/Unit)
Table 94. Global Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Application (2018-2023) & (K Units)
Table 95. Global Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Application (2024-2029) & (K Units)
Table 96. Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Application (2018-2023) & (USD Million)
Table 97. Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Application (2024-2029) & (USD Million)
Table 98. Global Point-of-care Testing (POCT) for Substance Abuse Average Price by Application (2018-2023) & (US$/Unit)
Table 99. Global Point-of-care Testing (POCT) for Substance Abuse Average Price by Application (2024-2029) & (US$/Unit)
Table 100. North America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Type (2018-2023) & (K Units)
Table 101. North America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Type (2024-2029) & (K Units)
Table 102. North America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Application (2018-2023) & (K Units)
Table 103. North America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Application (2024-2029) & (K Units)
Table 104. North America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Country (2018-2023) & (K Units)
Table 105. North America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Country (2024-2029) & (K Units)
Table 106. North America Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Country (2018-2023) & (USD Million)
Table 107. North America Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Europe Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Type (2018-2023) & (K Units)
Table 109. Europe Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Type (2024-2029) & (K Units)
Table 110. Europe Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Application (2018-2023) & (K Units)
Table 111. Europe Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Application (2024-2029) & (K Units)
Table 112. Europe Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Country (2018-2023) & (K Units)
Table 113. Europe Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Country (2024-2029) & (K Units)
Table 114. Europe Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Country (2018-2023) & (USD Million)
Table 115. Europe Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Country (2024-2029) & (USD Million)
Table 116. Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Type (2018-2023) & (K Units)
Table 117. Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Type (2024-2029) & (K Units)
Table 118. Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Application (2018-2023) & (K Units)
Table 119. Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Application (2024-2029) & (K Units)
Table 120. Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Region (2018-2023) & (K Units)
Table 121. Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Region (2024-2029) & (K Units)
Table 122. Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Region (2018-2023) & (USD Million)
Table 123. Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Region (2024-2029) & (USD Million)
Table 124. South America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Type (2018-2023) & (K Units)
Table 125. South America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Type (2024-2029) & (K Units)
Table 126. South America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Application (2018-2023) & (K Units)
Table 127. South America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Application (2024-2029) & (K Units)
Table 128. South America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Country (2018-2023) & (K Units)
Table 129. South America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Country (2024-2029) & (K Units)
Table 130. South America Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Country (2018-2023) & (USD Million)
Table 131. South America Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Country (2024-2029) & (USD Million)
Table 132. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Type (2018-2023) & (K Units)
Table 133. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Type (2024-2029) & (K Units)
Table 134. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Application (2018-2023) & (K Units)
Table 135. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Application (2024-2029) & (K Units)
Table 136. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Region (2018-2023) & (K Units)
Table 137. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Region (2024-2029) & (K Units)
Table 138. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Region (2018-2023) & (USD Million)
Table 139. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Region (2024-2029) & (USD Million)
Table 140. Point-of-care Testing (POCT) for Substance Abuse Raw Material
Table 141. Key Manufacturers of Point-of-care Testing (POCT) for Substance Abuse Raw Materials
Table 142. Point-of-care Testing (POCT) for Substance Abuse Typical Distributors
Table 143. Point-of-care Testing (POCT) for Substance Abuse Typical Customers
Table 1. Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 6. Roche Point-of-care Testing (POCT) for Substance Abuse Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Roche Recent Developments/Updates
Table 8. Danaher Basic Information, Manufacturing Base and Competitors
Table 9. Danaher Major Business
Table 10. Danaher Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 11. Danaher Point-of-care Testing (POCT) for Substance Abuse Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Danaher Recent Developments/Updates
Table 13. Abbott Basic Information, Manufacturing Base and Competitors
Table 14. Abbott Major Business
Table 15. Abbott Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 16. Abbott Point-of-care Testing (POCT) for Substance Abuse Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Abbott Recent Developments/Updates
Table 18. Siemens Basic Information, Manufacturing Base and Competitors
Table 19. Siemens Major Business
Table 20. Siemens Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 21. Siemens Point-of-care Testing (POCT) for Substance Abuse Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Siemens Recent Developments/Updates
Table 23. Beijing Hotgen Biotech Basic Information, Manufacturing Base and Competitors
Table 24. Beijing Hotgen Biotech Major Business
Table 25. Beijing Hotgen Biotech Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 26. Beijing Hotgen Biotech Point-of-care Testing (POCT) for Substance Abuse Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Beijing Hotgen Biotech Recent Developments/Updates
Table 28. Hangzhou Biotest Biotech CO.,LTD Basic Information, Manufacturing Base and Competitors
Table 29. Hangzhou Biotest Biotech CO.,LTD Major Business
Table 30. Hangzhou Biotest Biotech CO.,LTD Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 31. Hangzhou Biotest Biotech CO.,LTD Point-of-care Testing (POCT) for Substance Abuse Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Hangzhou Biotest Biotech CO.,LTD Recent Developments/Updates
Table 33. Assure Tech Basic Information, Manufacturing Base and Competitors
Table 34. Assure Tech Major Business
Table 35. Assure Tech Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 36. Assure Tech Point-of-care Testing (POCT) for Substance Abuse Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Assure Tech Recent Developments/Updates
Table 38. Orient Gene Basic Information, Manufacturing Base and Competitors
Table 39. Orient Gene Major Business
Table 40. Orient Gene Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 41. Orient Gene Point-of-care Testing (POCT) for Substance Abuse Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Orient Gene Recent Developments/Updates
Table 43. Thermo Fisher Basic Information, Manufacturing Base and Competitors
Table 44. Thermo Fisher Major Business
Table 45. Thermo Fisher Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 46. Thermo Fisher Point-of-care Testing (POCT) for Substance Abuse Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Thermo Fisher Recent Developments/Updates
Table 48. Guangzhou Wondfo Biotech Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 49. Guangzhou Wondfo Biotech Co.,Ltd. Major Business
Table 50. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 51. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments/Updates
Table 53. Hangzhou Alltest Biotech Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 54. Hangzhou Alltest Biotech Co.,Ltd. Major Business
Table 55. Hangzhou Alltest Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 56. Hangzhou Alltest Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Hangzhou Alltest Biotech Co.,Ltd. Recent Developments/Updates
Table 58. Beckman Coulter Basic Information, Manufacturing Base and Competitors
Table 59. Beckman Coulter Major Business
Table 60. Beckman Coulter Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 61. Beckman Coulter Point-of-care Testing (POCT) for Substance Abuse Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Beckman Coulter Recent Developments/Updates
Table 63. Bio-Rad Basic Information, Manufacturing Base and Competitors
Table 64. Bio-Rad Major Business
Table 65. Bio-Rad Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 66. Bio-Rad Point-of-care Testing (POCT) for Substance Abuse Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Bio-Rad Recent Developments/Updates
Table 68. BioMerieux Basic Information, Manufacturing Base and Competitors
Table 69. BioMerieux Major Business
Table 70. BioMerieux Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 71. BioMerieux Point-of-care Testing (POCT) for Substance Abuse Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. BioMerieux Recent Developments/Updates
Table 73. Global Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 74. Global Point-of-care Testing (POCT) for Substance Abuse Revenue by Manufacturer (2018-2023) & (USD Million)
Table 75. Global Point-of-care Testing (POCT) for Substance Abuse Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 76. Market Position of Manufacturers in Point-of-care Testing (POCT) for Substance Abuse, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 77. Head Office and Point-of-care Testing (POCT) for Substance Abuse Production Site of Key Manufacturer
Table 78. Point-of-care Testing (POCT) for Substance Abuse Market: Company Product Type Footprint
Table 79. Point-of-care Testing (POCT) for Substance Abuse Market: Company Product Application Footprint
Table 80. Point-of-care Testing (POCT) for Substance Abuse New Market Entrants and Barriers to Market Entry
Table 81. Point-of-care Testing (POCT) for Substance Abuse Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Region (2018-2023) & (K Units)
Table 83. Global Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Region (2024-2029) & (K Units)
Table 84. Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Region (2018-2023) & (USD Million)
Table 85. Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Region (2024-2029) & (USD Million)
Table 86. Global Point-of-care Testing (POCT) for Substance Abuse Average Price by Region (2018-2023) & (US$/Unit)
Table 87. Global Point-of-care Testing (POCT) for Substance Abuse Average Price by Region (2024-2029) & (US$/Unit)
Table 88. Global Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Global Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Global Point-of-care Testing (POCT) for Substance Abuse Average Price by Type (2018-2023) & (US$/Unit)
Table 93. Global Point-of-care Testing (POCT) for Substance Abuse Average Price by Type (2024-2029) & (US$/Unit)
Table 94. Global Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Application (2018-2023) & (K Units)
Table 95. Global Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Application (2024-2029) & (K Units)
Table 96. Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Application (2018-2023) & (USD Million)
Table 97. Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Application (2024-2029) & (USD Million)
Table 98. Global Point-of-care Testing (POCT) for Substance Abuse Average Price by Application (2018-2023) & (US$/Unit)
Table 99. Global Point-of-care Testing (POCT) for Substance Abuse Average Price by Application (2024-2029) & (US$/Unit)
Table 100. North America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Type (2018-2023) & (K Units)
Table 101. North America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Type (2024-2029) & (K Units)
Table 102. North America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Application (2018-2023) & (K Units)
Table 103. North America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Application (2024-2029) & (K Units)
Table 104. North America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Country (2018-2023) & (K Units)
Table 105. North America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Country (2024-2029) & (K Units)
Table 106. North America Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Country (2018-2023) & (USD Million)
Table 107. North America Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Europe Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Type (2018-2023) & (K Units)
Table 109. Europe Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Type (2024-2029) & (K Units)
Table 110. Europe Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Application (2018-2023) & (K Units)
Table 111. Europe Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Application (2024-2029) & (K Units)
Table 112. Europe Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Country (2018-2023) & (K Units)
Table 113. Europe Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Country (2024-2029) & (K Units)
Table 114. Europe Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Country (2018-2023) & (USD Million)
Table 115. Europe Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Country (2024-2029) & (USD Million)
Table 116. Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Type (2018-2023) & (K Units)
Table 117. Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Type (2024-2029) & (K Units)
Table 118. Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Application (2018-2023) & (K Units)
Table 119. Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Application (2024-2029) & (K Units)
Table 120. Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Region (2018-2023) & (K Units)
Table 121. Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Region (2024-2029) & (K Units)
Table 122. Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Region (2018-2023) & (USD Million)
Table 123. Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Region (2024-2029) & (USD Million)
Table 124. South America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Type (2018-2023) & (K Units)
Table 125. South America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Type (2024-2029) & (K Units)
Table 126. South America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Application (2018-2023) & (K Units)
Table 127. South America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Application (2024-2029) & (K Units)
Table 128. South America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Country (2018-2023) & (K Units)
Table 129. South America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Country (2024-2029) & (K Units)
Table 130. South America Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Country (2018-2023) & (USD Million)
Table 131. South America Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Country (2024-2029) & (USD Million)
Table 132. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Type (2018-2023) & (K Units)
Table 133. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Type (2024-2029) & (K Units)
Table 134. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Application (2018-2023) & (K Units)
Table 135. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Application (2024-2029) & (K Units)
Table 136. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Region (2018-2023) & (K Units)
Table 137. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales Quantity by Region (2024-2029) & (K Units)
Table 138. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Region (2018-2023) & (USD Million)
Table 139. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Region (2024-2029) & (USD Million)
Table 140. Point-of-care Testing (POCT) for Substance Abuse Raw Material
Table 141. Key Manufacturers of Point-of-care Testing (POCT) for Substance Abuse Raw Materials
Table 142. Point-of-care Testing (POCT) for Substance Abuse Typical Distributors
Table 143. Point-of-care Testing (POCT) for Substance Abuse Typical Customers
LIST OF FIGURES
Figure 1. Point-of-care Testing (POCT) for Substance Abuse Picture
Figure 2. Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value Market Share by Type in 2022
Figure 4. Based on Colloidal Gold Examples
Figure 5. Based on Fluorescence Immunochromatography Examples
Figure 6. Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Diagnostic Center Examples
Figure 10. Road Traffic Safety Examples
Figure 11. Military Examples
Figure 12. Others Examples
Figure 13. Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Point-of-care Testing (POCT) for Substance Abuse Sales Quantity (2018-2029) & (K Units)
Figure 16. Global Point-of-care Testing (POCT) for Substance Abuse Average Price (2018-2029) & (US$/Unit)
Figure 17. Global Point-of-care Testing (POCT) for Substance Abuse Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Point-of-care Testing (POCT) for Substance Abuse by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Point-of-care Testing (POCT) for Substance Abuse Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Point-of-care Testing (POCT) for Substance Abuse Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Point-of-care Testing (POCT) for Substance Abuse Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Point-of-care Testing (POCT) for Substance Abuse Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Point-of-care Testing (POCT) for Substance Abuse Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Point-of-care Testing (POCT) for Substance Abuse Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Point-of-care Testing (POCT) for Substance Abuse Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Point-of-care Testing (POCT) for Substance Abuse Average Price by Type (2018-2029) & (US$/Unit)
Figure 32. Global Point-of-care Testing (POCT) for Substance Abuse Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Point-of-care Testing (POCT) for Substance Abuse Average Price by Application (2018-2029) & (US$/Unit)
Figure 35. North America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Point-of-care Testing (POCT) for Substance Abuse Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Point-of-care Testing (POCT) for Substance Abuse Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Point-of-care Testing (POCT) for Substance Abuse Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Point-of-care Testing (POCT) for Substance Abuse Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Point-of-care Testing (POCT) for Substance Abuse Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Point-of-care Testing (POCT) for Substance Abuse Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Point-of-care Testing (POCT) for Substance Abuse Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Point-of-care Testing (POCT) for Substance Abuse Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Point-of-care Testing (POCT) for Substance Abuse Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Point-of-care Testing (POCT) for Substance Abuse Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Point-of-care Testing (POCT) for Substance Abuse Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Point-of-care Testing (POCT) for Substance Abuse Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Point-of-care Testing (POCT) for Substance Abuse Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Consumption Value Market Share by Region (2018-2029)
Figure 55. China Point-of-care Testing (POCT) for Substance Abuse Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Point-of-care Testing (POCT) for Substance Abuse Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Point-of-care Testing (POCT) for Substance Abuse Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Point-of-care Testing (POCT) for Substance Abuse Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Point-of-care Testing (POCT) for Substance Abuse Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Point-of-care Testing (POCT) for Substance Abuse Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Point-of-care Testing (POCT) for Substance Abuse Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Point-of-care Testing (POCT) for Substance Abuse Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Point-of-care Testing (POCT) for Substance Abuse Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Point-of-care Testing (POCT) for Substance Abuse Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Point-of-care Testing (POCT) for Substance Abuse Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Point-of-care Testing (POCT) for Substance Abuse Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Point-of-care Testing (POCT) for Substance Abuse Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Point-of-care Testing (POCT) for Substance Abuse Market Drivers
Figure 76. Point-of-care Testing (POCT) for Substance Abuse Market Restraints
Figure 77. Point-of-care Testing (POCT) for Substance Abuse Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Point-of-care Testing (POCT) for Substance Abuse in 2022
Figure 80. Manufacturing Process Analysis of Point-of-care Testing (POCT) for Substance Abuse
Figure 81. Point-of-care Testing (POCT) for Substance Abuse Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Figure 1. Point-of-care Testing (POCT) for Substance Abuse Picture
Figure 2. Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value Market Share by Type in 2022
Figure 4. Based on Colloidal Gold Examples
Figure 5. Based on Fluorescence Immunochromatography Examples
Figure 6. Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Diagnostic Center Examples
Figure 10. Road Traffic Safety Examples
Figure 11. Military Examples
Figure 12. Others Examples
Figure 13. Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Point-of-care Testing (POCT) for Substance Abuse Sales Quantity (2018-2029) & (K Units)
Figure 16. Global Point-of-care Testing (POCT) for Substance Abuse Average Price (2018-2029) & (US$/Unit)
Figure 17. Global Point-of-care Testing (POCT) for Substance Abuse Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Point-of-care Testing (POCT) for Substance Abuse by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Point-of-care Testing (POCT) for Substance Abuse Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Point-of-care Testing (POCT) for Substance Abuse Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Point-of-care Testing (POCT) for Substance Abuse Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Point-of-care Testing (POCT) for Substance Abuse Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Point-of-care Testing (POCT) for Substance Abuse Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Point-of-care Testing (POCT) for Substance Abuse Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Point-of-care Testing (POCT) for Substance Abuse Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Point-of-care Testing (POCT) for Substance Abuse Average Price by Type (2018-2029) & (US$/Unit)
Figure 32. Global Point-of-care Testing (POCT) for Substance Abuse Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Point-of-care Testing (POCT) for Substance Abuse Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Point-of-care Testing (POCT) for Substance Abuse Average Price by Application (2018-2029) & (US$/Unit)
Figure 35. North America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Point-of-care Testing (POCT) for Substance Abuse Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Point-of-care Testing (POCT) for Substance Abuse Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Point-of-care Testing (POCT) for Substance Abuse Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Point-of-care Testing (POCT) for Substance Abuse Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Point-of-care Testing (POCT) for Substance Abuse Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Point-of-care Testing (POCT) for Substance Abuse Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Point-of-care Testing (POCT) for Substance Abuse Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Point-of-care Testing (POCT) for Substance Abuse Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Point-of-care Testing (POCT) for Substance Abuse Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Point-of-care Testing (POCT) for Substance Abuse Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Point-of-care Testing (POCT) for Substance Abuse Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Point-of-care Testing (POCT) for Substance Abuse Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Point-of-care Testing (POCT) for Substance Abuse Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Point-of-care Testing (POCT) for Substance Abuse Consumption Value Market Share by Region (2018-2029)
Figure 55. China Point-of-care Testing (POCT) for Substance Abuse Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Point-of-care Testing (POCT) for Substance Abuse Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Point-of-care Testing (POCT) for Substance Abuse Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Point-of-care Testing (POCT) for Substance Abuse Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Point-of-care Testing (POCT) for Substance Abuse Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Point-of-care Testing (POCT) for Substance Abuse Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Point-of-care Testing (POCT) for Substance Abuse Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Point-of-care Testing (POCT) for Substance Abuse Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Point-of-care Testing (POCT) for Substance Abuse Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Point-of-care Testing (POCT) for Substance Abuse Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Point-of-care Testing (POCT) for Substance Abuse Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Point-of-care Testing (POCT) for Substance Abuse Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Point-of-care Testing (POCT) for Substance Abuse Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Point-of-care Testing (POCT) for Substance Abuse Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Point-of-care Testing (POCT) for Substance Abuse Market Drivers
Figure 76. Point-of-care Testing (POCT) for Substance Abuse Market Restraints
Figure 77. Point-of-care Testing (POCT) for Substance Abuse Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Point-of-care Testing (POCT) for Substance Abuse in 2022
Figure 80. Manufacturing Process Analysis of Point-of-care Testing (POCT) for Substance Abuse
Figure 81. Point-of-care Testing (POCT) for Substance Abuse Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
